Clinuvel Pharmaceuticals
CUV.AX
#6575
Rank
C$0.65 B
Marketcap
$13.01
Share price
-2.77%
Change (1 day)
-3.88%
Change (1 year)

Earnings for Clinuvel Pharmaceuticals (CUV.AX)

Earnings in 2023: C$41.19 M

According to Clinuvel Pharmaceuticals's latest financial reports the company's current earnings (TTM) are C$41.19 M. In 2023 the company made an earning of C$41.19 M an increase over its 2022 earnings that were of C$32.18 M.The earnings displayed on this page is the company's Pretax Income.

Earnings history for Clinuvel Pharmaceuticals from 2000 to 2023

Annual earnings

Year Earnings Change
2023C$41.19 M27.99%
2022C$32.18 M23.07%
2021C$26.15 M113.01%
2020C$12.27 M-28.83%
2019C$17.25 M32.76%
2018C$12.99 M75.41%
2017C$7.4 M-333.26%
2016-C$3.18 M-70.84%
2015-C$10.9 M54.22%
2014-C$7.07 M-16.25%
2013-C$8.44 M-37.85%
2012-C$13.57 M-17.76%
2011-C$16.5 M24.04%
2010-C$13.31 M-20.92%
2009-C$16.82 M-11.54%
2008-C$19.02 M80.4%
2007-C$10.54 M-2.46%
2006-C$10.81 M-5.35%
2005-C$11.42 M60.55%
2004-C$7.11 M97.37%
2003-C$3.61 M50.62%
2002-C$2.4 M121.22%
2001-C$1.09 M254.48%
2000-C$0.31 M